Stay updated with breaking news from Bronchus cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan reduced the risk of disease progression or death by 25% in overall population and by 37% in patients with non-squamous tumors
/PRNewswire/ Prominently featured in The Inner Circle, Jahaira L. Serrano, MD, FACCP, is acknowledged as a Pinnacle Life Achiever for her contributions to. ....